A Single-Arm Prospective Investigation of the Effects of Laughter Therapy on Mood, Stress, and Self-Efficacy in People With Central Nervous System Disorders.
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 24
- 试验地点
- 2
- 主要终点
- Patient Health Questionnaire (PHQ-9, for depression)
研究概览
简要总结
This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.
详细描述
Laughter therapy (LT) has potential benefits in treating illness. It combines laughter with breathing and body exercises to stimulate laughter, both real and artificial, in a group setting. Laughter therapy may help treating illness by strengthening breathing muscles, improving mood, and providing pain and stress relief. EvergreenHealth has presented laughter therapy classes to patients with Parkinson's disease and Multiple sclerosis and other neurological conditions. The therapy will be led by a certified laughter therapist and mental health professional.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis based on medical record review of one of the following neurological diseases: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, Multiple Sclerosis, Parkinson's Disease, Post-Stroke, Spinal Cord Injury.
- •Medically stable for at least 2 months.
- •Not participating in Laughter therapy for 30 days prior to screening.
排除标准
- •Females who are pregnant
- •Any unstable medical condition
- •Severe cognitive deficits that would interfere with participation (e.g. unable to follow commands).
- •Severe abdominal pain, chest pain or back pain.
- •Abdominal, chest or back surgery within 90 days.
- •Psychosis or severe mental illness.
- •Untreated hernia.
- •Persistent cough.
- •Advanced hemorrhoids.
- •Epilepsy.
- •Uncontrolled Hypertension - SBP >170 or DBP >105.
研究组 & 干预措施
Laughter therapy
effects of Laughter therapy (LT) on mood, self-efficacy and other wellness measures in people with neurological conditions.
干预措施: Laughter Therapy (Other)
结局指标
主要结局
Patient Health Questionnaire (PHQ-9, for depression)
时间窗: Change from Baseline to 8 weeks
Outcome measures will be completed at baseline, active-phase completion at week 8 and post-active phase week 8 (16 weeks post-start of active phase).
Generalized Anxiety Disorder 7-item scale (GAD-7, for anxiety)
时间窗: Change from Baseline to 8 weeks
Outcome measures will be completed at baseline, active-phase completion at week 8 and post-active phase week 8 (16 weeks post-start of active phase).
次要结局
- The General Self-Efficacy Scale (GSE)(Change from Baseline to 8 weeks)
研究者
Theodore R Brown
M.D., MPH
Brown, Theodore R., M.D., MPH